OverStitch NXT Endoscopic Suture System
ConditionWeight Loss
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBoston Scientific Corporation
About this trial
To demonstrate the safety and efficacy of OverStitch NXT Endoscopic Suture System for endoscopic sleeve gastroplasty（ESG） in obese populations to support the registration of OverStitch NXT for ESG indication.
Eligibility criteria
Qualifiers
Aged 18 years or older, or subjects who have reached the legal age for signing informed consent in accordance with local laws and regulations.
BMI ≥ 32.5 kg/m²; or BMI ≥ 27.5 kg/m² combined with type 2 diabetes mellitus (regardless of the effectiveness of medical treatment for type 2 diabetes); or BMI between 27.5 kg/m² and 32.5 kg/m² with ineffective medical weight loss or combined with other obesity-related diseases for which medical treatment is ineffective.
Willing to comply with the long-term strict dietary restrictions required by the surgery.
Capable of providing informed consent, able to complete all routine follow-up visits, and willing to abide by the protocol requirements, including signing the informed consent form, completing relevant examinations, and receiving dietary counseling.
Disqualifiers
History of foregut or gastrointestinal (GI) surgery (except uncomplicated cholecystectomy or appendectomy)
Prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions.
Prior open or laparoscopic bariatric surgery.
Prior surgery of any kind on the esophagus or any type of hiatal hernia surgery.
Trial design
Treatments tested in this trial
- OverStitch NXT Endoscopic Suture System
Treatment groups
136 Participants
are divided into 3 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
Boston Scientific Corporation
Lead sponsor
Source ClinicalTrials.gov